在药品中使用人为驱动的生成AI
Yun Wan1, Makoto Nakayama2, Cesar Floyd Aldana3
1University of Houston-Downtown, 1 Main Street, Houston, TX 77002, United States.
Drug discovery today
|November 3, 2025
概括
个性驱动的生成人工智能 (GenAI) 通过改善药物开发中的人工智能-人类合作来增强药品创新. 这些先进的AI工具显示出显著的时间线减少和效率提升,尽管在验证和偏见管理方面存在持续的挑战.
科学领域:
- 制药科学 制药科学
- 人工智能的人工智能
- 药物开发 药物开发
背景情况:
- 生成型人工智能 (GenAI) 为人工智能与人类在制药创新的合作提供了新的框架.
- 最近的进展侧重于跨药物发现,临床试验和患者参与的应用.
研究的目的:
- 检查人为驱动的GenAI在制药创新的最新应用 (2023-2025年).
- 评估GenAI对药物开发时间表和效率的影响.
主要方法:
- 审查GenAI在药物研发中的最新应用,包括目标识别和临床开发.
- 对AlphaFold 3,数字双胞胎验证和人工智能驱动的监管智能等关键发展的分析.
- 通过上下文原始化和领域专业知识评估以人为本的GenAI绩效提升.
主要成果:
- 基因人工智能应用程序在蛋白质结构预测和监管智能方面取得了突破.
- 个性驱动的GenAI显著提高了制药环境中的性能.
- 开发时间缩短了60-70%,提高了临床试验的效率.
结论:
- 个人驱动的GenAI为制药创新提供了变革性的机会.
- 关键的挑战包括幻觉缓解,偏见管理和监管验证以实现广泛采用.
- 基因人工智能集成有望加速药物开发和改善患者沟通.
相关概念视频
Non-equilibrium in the Cell
5.3K
An important concept in studying metabolism and energy is that of chemical equilibrium. Most chemical reactions are reversible. They can proceed in both directions, releasing energy into their environment in one direction, and absorbing it from the environment in the other direction. The same is true for the chemical reactions involved in cell metabolism, such as the breaking down and building up of proteins into and from individual amino acids, respectively. Reactants within a closed system...
5.3K
Microorganisms in Medicine and Therapeutics
925
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
925
Biopharmaceutical Factors Influencing Drug Product Design: Overview
227
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
227
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Pharmaceutical Equivalents
173
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
173
Prodrugs
3.9K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
3.9K


